CXCR4 and idiopathic pulmonary fibrosis: For IPF patients treated with antifibrotic pirfenidone, the CXCR4 expression on the follow-up PET scan after treatment emerged as an independent prognostic predictor wherein elevated pulmonary CXCR4 signal was associated with markedly worse long-term outcomes [39].